Atrium Therapeutics, Inc. (RNA)

Atrium Therapeutics, Inc. (RNA) is a healthcare company (biotechnology) based in the United States. The share price is $6.51, up 1.24% on the day, which values the company at $140.43M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$6.51+1.24% today
Market value
$140.43M
Funk Score
67/100
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Atrium Therapeutics, Inc. in more detail

RNA trades at -1.1× next year's expected earnings, 3.6× sales.

Over the last five fiscal years Atrium Therapeutics, Inc. has compounded revenue 22.4% a year. Its Funk Score is 67 out of 100 (financial strength 8.1, profitability 2.5, growth 9.3, each out of 10).

In its favour: More cash than debt. Worth checking: Heavy stock-based pay.

Atrium Therapeutics, Inc. (RNA): questions and answers

What is Atrium Therapeutics, Inc.'s market cap?

Atrium Therapeutics, Inc. is valued at $140.43M at a share price of $6.51.

How fast is Atrium Therapeutics, Inc. growing?

Over the last five fiscal years Atrium Therapeutics, Inc.'s revenue grew 22.4% a year.

Does RNA pay a dividend?

Atrium Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Atrium Therapeutics, Inc. (RNA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RNA

Underlying data: Yahoo Finance; company filings with the SEC.